Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
GeneMe, a Poland-based universal molecular genetic tests platform spun out of Institute of Biotechnology and Molecular Medicine, has closed a €5.2m ($6.4m) seed round led by Robin Tombs, with participation from other angel investors, TechCrunch reported yesterday. The spinout’s offering includes three tests for covid-19. GeneMe’s technology can be assembled at the point of care and offers both highly accurate and rapid results.
MaxWell Biosystems, a Switzerland-based spinout of ETH Zürich that is using electrophysiology technology to discover and…
